Cargutocin is a synthetic oxytocin analogue classified as a uterotonic agent used to induce myometrial contraction for the management of postpartum hemorrhage and the prevention of excessive bleeding following… Read more
Cargutocin is a synthetic oxytocin analogue classified as a uterotonic agent used to induce myometrial contraction for the management of postpartum hemorrhage and the prevention of excessive bleeding following childbirth. This category features high-quality reference standards of this compound and its stable isotope labelled forms, such as Cargutocin-d7, which are essential tools for pharmaceutical analysis. Laboratories utilize these compounds for precise impurity profiling, method validation, and rigorous quality control protocols during the manufacturing of oxytocin receptor agonists. The inclusion of deuterated derivatives allows researchers to employ these reference standards as internal standards in mass spectrometry-based assays, facilitating accurate quantification in pharmacokinetic studies and ensuring the stability and safety of the final pharmaceutical product. By providing consistent and reliable analytical markers, these reference materials support the development and regulatory compliance of potent therapeutic agents designed to improve maternal health outcomes.